As of 2024-12-15, the Intrinsic Value of Landos Biopharma Inc (LABP) is
-39.61 USD. This LABP valuation is based on the model Peter Lynch Fair Value.
With the current market price of 22.93 USD, the upside of Landos Biopharma Inc is
-272.74%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-39.61 USD
Intrinsic Value
LABP Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-39.61 - -39.61 |
-39.61 |
-272.74% |
P/E |
(175.39) - (198.37) |
(170.92) |
-845.4% |
DDM - Stable |
(66.47) - (334.96) |
(200.71) |
-975.3% |
DDM - Multi |
(52.20) - (214.95) |
(85.20) |
-471.6% |
LABP Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
71.77 |
Beta |
0.70 |
Outstanding shares (mil) |
3.13 |
Enterprise Value (mil) |
42.77 |
Market risk premium |
4.60% |
Cost of Equity |
9.19% |
Cost of Debt |
5.00% |
WACC |
6.43% |